Mereo BioPharma Group plc
MREO
$2.30
$0.177.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.31% | -7.90% | 79.68% | -15.26% | 7.30% |
| Total Receivables | 17.50% | 17.38% | 22.57% | -47.40% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -81.40% | 0.85% | -21.44% | 130.35% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.26% | -24.69% | 187.67% | -57.52% | -- |
| Total Current Assets | -13.79% | -7.68% | 75.60% | -16.10% | -- |
|
|
|||||
| Total Current Assets | -13.79% | -7.68% | 75.60% | -16.10% | -- |
| Net Property, Plant & Equipment | -19.61% | -7.48% | -9.94% | -10.97% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.52% | -7.74% | -10.91% | -10.74% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.92% | -7.68% | 71.85% | -15.88% | -- |
|
|
|||||
| Total Accounts Payable | 34.90% | -43.41% | 42.73% | 4.65% | -- |
| Total Accrued Expenses | -18.03% | -7.28% | 105.39% | -49.02% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.72% | 12.07% | 6.01% | 711.66% | -- |
| Total Finance Division Other Current Liabilities | -0.28% | 7.19% | 2.14% | -55.87% | -- |
| Total Other Current Liabilities | -0.28% | 7.19% | 2.14% | -55.87% | -- |
| Total Current Liabilities | -2.53% | -8.13% | 40.55% | 16.00% | -- |
|
|
|||||
| Total Current Liabilities | -2.53% | -8.13% | 40.55% | 16.00% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.54% | -28.62% | -24.07% | -19.76% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.81% | 10.06% | 6.80% | 16.33% | -- |
| Total Liabilities | -4.87% | -7.26% | 33.44% | -17.94% | -- |
|
|
|||||
| Common Stock & APIC | 0.60% | 0.32% | 9.81% | 0.17% | -- |
| Retained Earnings | -1.55% | -3.40% | -2.86% | -2.13% | -- |
| Treasury Stock & Other | -69.75% | 39.25% | 0.03% | 2.31% | -- |
| Total Common Equity | -15.95% | -7.77% | 83.60% | -15.23% | -31.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.95% | -7.77% | 83.60% | -15.23% | -31.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.95% | -7.77% | 83.60% | -15.23% | -31.13% |
|
|
|||||